comparemela.com
Home
Live Updates
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights : comparemela.com
Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
-Contineum is focused on leading the Neuroscience, Inflammation and Immunology field-
-Successful completion of Initial Public Offering with strong syndicate of existing and new investors-
...
Related Keywords
San Diego ,
California ,
United States ,
Carmine Stengone ,
Third Development ,
Contineum Therapeutics Inc ,
Arcellx Inc ,
Davidson College ,
Johnson ,
Nasdaq ,
Development Expenses ,
Drug Administration ,
Revance Therapeutics Inc ,
University Of North Carolina At Chapel Hill ,
Contineum Therapeutics ,
Chief Executive ,
Recent Business ,
Extended Cash Runway Through ,
Initial Public ,
Secondary Objectives ,
Pipeline Through ,
Third Development Candidate ,
Investigational New Drug Application ,
Myelin Gordon ,
Myelin Gordon Conference ,
Olivia Ware ,
Revance Therapeutics ,
North Carolina ,
Cash Equivalents ,
Johnson Innovative ,
Financial Condition ,
Months Ended March ,
comparemela.com © 2020. All Rights Reserved.